CBGL (Cannabis Global) YoY EBITDA Growth: -100.00% (As of May. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cannabis Global YoY EBITDA Growth?

Cannabis Global CBGL YoY EBITDA Growth is -100.00% as of May. 2022.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cannabis Global's YoY EBITDA Growth for the quarter that ended in May. 2022 was -100.00%.

Cannabis Global's EBITDA per Share for the three months ended in May. 2022 was $0.00.

Cannabis Global YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Cannabis Global's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabis Global YoY EBITDA Growth Chart

Cannabis Global Annual Data
Trend Aug12 Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 100.00 0.00 -342.86 -561.29 95.12

Cannabis Global Quarterly Data
Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 106.63 -23.53 -80.95 350.00 -100.00

Cannabis Global YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cannabis Global's YoY EBITDA Growth for the fiscal year that ended in Aug. 2021 is calculated as:

YoY EBITDA Growth (A: Aug. 2021 )
=(EBITDA per Share (A: Aug. 2021 )-EBITDA per Share (A: Aug. 2020 ))/ | EBITDA per Share (A: Aug. 2020 ) |
=(-0.01--0.205)/ | -0.205 |
=95.12 %

Cannabis Global's YoY EBITDA Growth for the quarter that ended in May. 2022 is calculated as:

YoY EBITDA Growth (Q: May. 2022 )
=(EBITDA per Share (Q: May. 2022 )-EBITDA per Share (Q: May. 2021 )) / | EBITDA per Share (Q: May. 2021 )) |
=(-0-0.013)/ | 0.013 |
=-100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -100.00% mean?
Cannabis Global (CBGL) has a YoY EBITDA Growth of -100.00% as of May. 2022. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Cannabis Global and its competitors.
Is Cannabis Global's YoY EBITDA Growth too high?
Cannabis Global's current YoY EBITDA Growth is -100.00%.
How does Cannabis Global's YoY EBITDA Growth compare to MILC and BBBT?
Cannabis Global's YoY EBITDA Growth of -100.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Cannabis Global and its competitors. Cannabis Global's current YoY EBITDA Growth is -100.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Global stock overvalued right now?
Cannabis Global (CBGL) has a current YoY EBITDA Growth of -100.00%. The current YoY EBITDA Growth is -100.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Cannabis Global (CBGL), the current YoY EBITDA Growth is -100.00% as of May. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabis Global Business Description

Address 520 S Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071
Cannabis Global Inc manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.